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Abstract
There is a strong tradition of therapy development and evaluation in the field of
psychological interventions for chronic pain. However, despite this research
production, the effects of treatments remain uncertain, and treatment
development has stalled. This review summarises the current evidence but
focusses on promising areas for improvement. Advancing psychological
therapies for chronic pain will come from a radical re-imagining of the content,
delivery, place, and control of therapy. The next generation of therapeutic
interventions will also need alternative methods of measurement and
evaluation, and options are discussed.
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Introduction
Psychological treatments—in particular, cognitive behaviour 
therapies—have been a mainstay of chronic pain management. 
The population of people who seek treatment for chronic pain is 
growing, and there is a rising incidence of chronic neuropathic 
pain1, the growing realisation of the burden of pain in later life2, 
and a recognition that performance of pharmacological interven-
tions is disappointing3. Despite the demand for treatment, progress 
in psychological therapy has now reached a turning point, and there 
is no clear direction on the route to take. This is a timely junc-
ture to look critically at the evidence we have, to understand why 
treatment development is failing, and to consider how to cut a 
new path to clinical progress.
Exploring the evidence base
The evidence for the efficacy of psychological interventions is 
largely underwhelming. There are four main Cochrane systematic 
reviews of psychological interventions for improving pain, affect, 
and disability in chronic pain—two with adults4,5 and two with 
adolescents4,6. This is not an under-researched area. Altogether, 
101 randomised controlled trials (RCTs) have been conducted. 
For adults, behavioural and cognitive behavioural treatments show 
moderate-effect sizes of benefit over waiting lists and small or no 
effects over active comparators for outcomes in pain, disability, 
and mood. However, uncertainty over the effect estimates remains 
high because of poor-quality and small studies. For treatments of 
children and adolescents, there is moderate-quality evidence of 
efficacy of cognitive behavioural therapy (CBT), in particular for 
headache, and evidence is developing for musculoskeletal pain 
conditions such as fibromyalgia7. The quality of recent trials in 
paediatrics is high, and there is innovation in methods of remote 
delivery8. In paediatric pain, however, there is an historical absence 
of evidence for non-pain outcomes such as psychological and 
physical functioning, and for non-patient stakeholders such as 
parents or siblings. From 101 RCTs, the best conclusion we can 
draw is that there is low-quality evidence of small to moderate 
effects of CBT for chronic pain, meaning that the effect estimates 
could easily change with new evidence.
Paradigm shift
Perhaps the next 101 trials will help us. Without change, however, 
we believe not. In 2013, we argued that there should be a halt on 
trial registration, until the quality and focus radically improve, 
because of a significant threat of research waste9. There should 
be no new trials until three critical problems are addressed. First, 
treatment should be based on an extant model of behaviour change. 
In psychology, it is normal practice to run phase II or III studies 
without pre-clinical work or phase I study. Post hoc theorising 
is common. There should be a scientifically plausible reason for 
behaviour change, stated and mapped, and one should always 
assume the possibility of harm. Second, clinical endpoints of 
treatments and thresholds of treatment success should be estab-
lished by the community. At present, the field is awash with 
therapist- or researcher-driven measurement. Outcomes developed 
and determined by patients, with meaningful endpoints, will help 
enormously. Dichotomous outcomes of meaningful changes in 
health state are rarely reported, relying instead on the use of con-
tinuous variables aggregated across groups. Third, innovation will 
come only by creating pathways from pre-clinical to clinical stud-
ies, by better understanding patient need, by resisting the errant 
individualisation of social problems which position responsibility 
for change with the individual alone, and by challenging the habit 
of pathologising normal, albeit maladaptive, behaviour. A new 
paradigm for developing innovative treatment is needed, requiring 
both theoretical and methodological attention.
Novel targets for therapy development
There is promising work in four areas: in the search for common 
transdisciplinary mechanisms of therapeutic change, in better 
profiling of patient need and consequent tailoring of content, in 
exploring embodied pain models for analgesic as well as reha-
bilitative intervention, and in the use of computing technology to 
re-imagine therapeutic practice.
(1)  Like surgery, psychological intervention is dependent 
on the skill, training, and experience of the operator; 
is manufactured in the moment; and is tailored to the 
individual case. The overall small- to moderate-effect 
sizes of CBT hide a heterogeneity of content, operator 
characteristics, exposure time, and therapist allegiance, 
which go largely unreported. Individual candidate 
measures of process are often investigated, but common 
features of treatment go undiscussed. Burns has argued 
recently that attention to common mechanisms, in 
particular ‘behavioural activation’—actively engaging 
in practicing or experimenting with meaningful physical 
change—is a good candidate10,11. A further example is the 
need to account for parental distress, and parenting, in 
the treatment of adolescent chronic pain12. A novel target 
for therapy development is in making the non-specific 
specific.
(2)  Despite a large evidence base, there are critical gaps. 
Individual differences and the importance of pain 
presentation are rarely investigated. There is some 
consideration of sex differences in therapy outcomes13, 
of chronic pain in later life14, and of delivery in particular 
settings such as the workplace15. But these are rare cases. 
Odder still is the absence of data for specific populations. 
For example, we found only three RCTs of psychological 
interventions eligible for a Cochrane Review in chronic 
neuropathic pain16. Exactly how the form and content 
of pain shape psychological experience is largely 
unexplored, hidden within large compound variables 
such as anxiety, depression, or disability. The extent to 
which, for example, worry about headache is critically 
different from worry about pelvic pain is important, as 
is the history of the meaning of that pain (for example, 
whether it was related to previous disease). A novel target 
for therapy development is establishing illness-specific 
psychological theory.
(3)  Pain intrudes on awareness and functions to protect 
by urging escape and avoidance from potential harm. 
Repetitive inescapable interruption, motor preparation 
for flight, and heightened sensitivity to cues of danger 
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create a pain-dominated environment in which accurate 
prediction of action in the context of pain is difficult17. 
Recent theory in embodied pain suggests that the 
inherent uncertainty around experience might be a 
therapeutic opportunity, with potentially analgesic 
outcomes18. Experience-altering interventions using 
virtual and augmented reality19, anatomical education20, 
or exposure21 are interesting first forays into treatments 
aimed at directly altering experience. A fully embodied 
rehabilitation approach to chronic pain will embrace pain 
as always selected over competing demands for protection 
in the uncertain context of threat. A novel target for 
therapy development is to adopt an active psychology of 
meaningful engagement.
(4)  A frontier for psychological therapy is to embrace the 
possibilities of technology, not only in augmenting, 
supporting, or replacing the remote delivery of traditional 
face-to-face treatment but for novel therapy content. 
Technology can do what therapists cannot, and can 
do many things better. Technology can accompany 
the patient, measure multiple aspects of experience, 
render data into accurate information instantaneously, 
give immediate access to knowledge, send and receive 
messages in near real-time, and allow discourse, anytime 
and almost anywhere. The opportunities of technology 
have yet to be explored. A user-centred modern therapy 
would be delivered flexibly over multiple devices, be 
highly dependent on the small data people trail about 
their lives22, work just in time23, and be highly contextual, 
integrated, and relational17. A novel target for therapy 
development is to re-imagine therapy as active in the 
minutia of people’s lives, lives lived with technology rich 
in therapeutic promise.
Development of methods
Next-generation therapies for chronic pain, indeed for psychologi-
cal therapy in general, demand a new generation of methods. How 
we establish ‘what works for whom’ remains the critical challenge 
in pain science. Three areas deserve attention. First, there is a 
significant measurement problem in construct definition, independ-
ence, and relevance. Second, there is a unit-of-analysis problem. 
Individual experience is rarely investigated or reported, but the 
novel therapies discussed here will need sophisticated within- 
subject investigations. Finally, the quality of both conduct and 
reporting of studies needs to be considered and then improved.
(1) Psychology is largely concerned with behavioural as-
sessment and change. Some behaviour is observable by 
self and other (for example, a physical attitude or ges-
ture), and some is observable only by self (for example, 
a thought, emotion, belief, or bodily perception such as 
pain). The successful measurement of behaviour relies 
on the independence of a construct and on the quality of 
the measurement technology used to capture it. In pain, 
there is an active science of instrument development. 
Lost in pain research is a consideration of the importance 
of construct coherence even before the deployment of 
measurement technology. Here are three examples. 
We have shown that the measurement of acceptance of 
chronic pain is corrupted with content more pertinent to 
physical and social function, making it almost impossible 
to independently measure the role of function in altering 
acceptance, or vice versa24. There is little evidence that 
adolescents experience catastrophic thinking about pain, 
and what is normally measured is better described as 
worry25. And research into the popular construct of ‘so-
matisation’ is fundamentally flawed in pain research by 
the absence of demonstration that patients meet criteria 
for somatisation26. Needed is consideration of the con-
tent of measures beyond their labels, the reporting of data 
at an item level, a priori establishment of independence 
of constructs, and a consensus over meaningful clinical 
endpoints.
(2)  Also needed are within-subject idiographic methods. 
The randomised placebo-controlled trial is an ill-fitting 
method of assessing psychological treatment efficacy 
and safety and will be further challenged by individual, 
context-dependent, temporally dynamic therapies. 
Increased demands for data-sharing might allow for post 
hoc review of individual data, but they rely heavily on 
the availability and quality of trial data. Single-case se-
ries are often more relevant and are highly versatile and 
under-employed27. In pain, there is also a strong tradi-
tion of using ecological momentary assessment in which 
people report on behaviour when it occurs or at set inter-
vals of time28. The advent of pervasive communication 
technology being repurposed for therapeutic use makes 
it necessary to innovate single-case, personally situated, 
data-rich methods. There is research already in the use 
of big data29, and interesting development of a micro- 
randomised trial, that involves moving the randomisation 
point from pre-treatment to various points within treat-
ment. For example, one might randomise the delivery of a 
remote message prompt, within-patient, within-trial23.
(3)  The conduct of all studies in pain is likely to come 
under further scrutiny for how known biases are man-
aged and for the possibility of research misconduct, 
including fraud. Cochrane risk-of-bias assessment of all 
primary trials in psychological treatments shows general 
problems of reporting biases (for example, selective 
reporting) and performance bias (for example, lack 
of appropriate blinding). The emergence of reporting 
standards—for example, Consolidated Standards of 
Reporting Trials (CONSORT)—and the insistence by 
journals of trial registration are helpful developments; see 
www.equator-network.org. Further problems specific to 
trials of psychological interventions for chronic pain are 
the entering of patients to trial on the basis of criteria only 
indirectly relevant to treatment (for example, pain sever-
ity), entering of patients to trial with mild or no problems, 
failure to consider or report adverse events, and the selec-
tive or non-reporting of data. The extent to which these 
biases are systemic and arise from a failure of clinical 
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equipoise in pain psychology is unknown, although 
there are examples of authors arguing for treatment 
efficacy, when their data show no evidence of effect30. 
Understanding narrative bias will help authors judge the 
quality and impact of any efficacy investigation.
Conclusions
There has been tremendous industry in producing a large number 
of RCTs, and even more uncontrolled evaluations, of psychological 
interventions for outcomes in chronic pain. But uncertainty over 
efficacy and harm remains. A radical re-imagining of therapy for 
chronic pain is needed, not least by a consideration of the role of 
technology improving access to existing therapy, and the therapy 
itself. Directly altering pain through a consideration of embodied 
perception—an embodied pain approach—offers exciting avenues 
for exploration18. Making use of traces of data we leave from 
pervasive sensing and communication technology is especially 
promising. Methods of assessment and evaluation will also need to 
be developed, in particular to match therapy delivery that is tailored 
to individual needs or problems in ecological or natural environ-
ments. Guiding principles for advancing psychological therapies 
for chronic pain will be to ensure better translation from pre-clinical 
studies of pain and to protect equipoise from the threat of bias.
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